Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

The agency approved the first CGM for over-the-counter use in March. Stelo, by Dexcom, was approved for anyone 18 and older ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company specializing in designing, developing, and commercializing continuous glucose ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

However, there remain good reasons to invest in the company. Let's first review what DexCom does. The company is a leader in ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third ...

The U.S. spends $413 billion dollars each year on diabetes-related care, meaning that diabetic patients now account for one of every four healthcare dollars spent in the country. The first step in ...

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...